Page 2 - Global Access Program News Today

Roches 125th year anniversary: a history of sustainable innovation

/PRNewswire/ -- RestoringVision has reached an impressive milestone of providing 20 million people with clear vision. The global nonprofit enhances peoples...

1 and the growing challenge of drug resistance is adding to the global health crisis WHO guidelines support the expansion of tuberculosis diagnostics in resource-limited countries, enabling patients to receive timely diagnosis leading to proper treatment, which benefits their recovery and slows the transmission of disease Roche’s Global Access Program aids clinicians in improving disease and patient management through increased access to innovative diagnostic solutions, allowing more patient...

F. Hoffmann-La Roche Ltd WHO guidelines now include Roche’s diagnostic tests in expanded effort to eliminate tuberculosis by providing patients greater access to timely diagnosis WHO guidelines now include Roche’s diagnostic tests in expanded effort to eliminate tuberculosis by providing patients greater access to timely diagnosis Tuberculosis is a disease of poverty, and economic distress with 1.4 million deaths annually 1 and the growing challenge of drug resistance is adding to the glob...

Share this article Share this article ResearchAndMarkets.coms offering. The global cervical dysplasia market size is expected to reach USD 936.4 million by 2028 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth. The rising prevalence of cervical cancer and awareness regarding its early diagnosis is the key cervical dysplasia industry impacting factors. As per the report published by World Health Organization...

Share: ResearchAndMarkets.coms offering. The global cervical dysplasia market size is expected to reach USD 936.4 million by 2028 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth. The rising prevalence of cervical cancer and awareness regarding its early diagnosis is the key cervical dysplasia industry impacting factors. As per the report published by World Health Organization, in 2018, worldwide there were...

F. Hoffmann-La Roche Ltd Roche’s awarded WHO prequalification for the HIV and HCV diagnostic tests on the cobas 6800/8800 Systems Roche’s awarded WHO prequalification for the HIV and HCV diagnostic tests on the cobas 6800/8800 Systems For patients living in areas with limited healthcare resources, WHO prequalification ensures access to the highest quality diagnostics Access to broader reliable diagnostic solutions helps healthcare communities working to expedite and increase disease elimin...

BAE Systems Backs Local Tech Company with Global Defence Capability World leading 3D volumetric display technology developed by South Australian company Voxon Photonics has won new work with BAE Systems’ UK based submarine business and the Australian based Hunter Class Frigate program. The company will provide the Hunter Class Frigate program and the UK Submarines business with its bespoke displays to provide 3D visualisation...